Literature DB >> 10208879

The mouse ortholog of the human SMARCB1 gene encodes two splice forms.

C E Bruder1, J P Dumanski, D Kedra.   

Abstract

The human SMARCB1 gene (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily b, member 1, previously named the INI1/hSNF5 gene) is a tumor suppressor gene located on chromosome 22q11.2 and is inactivated in malignant rhabdoid tumors. By using an EST-based approach, we cloned two splice forms of the Smarcb1 gene in mouse and a longer splice form of the human ortholog. Proteins corresponding to the longer (385 aa) and the shorter (376 aa) forms are 100% conserved between human and mouse. Meningiomas and schwannomas are tumors frequently deleting various regions on chromosome 22, including the SMARCB1 locus. We therefore directly sequenced seven SMARCB1 exons (90% of the open reading frame) in search for mutations in 41 meningiomas and 23 schwannomas. No inactivating mutations were observed, which suggests that the SMARCB1 gene is not involved in the pathogenesis of these tumors. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208879     DOI: 10.1006/bbrc.1999.0563

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

Authors:  Scott R Plotkin; Jaishri O Blakeley; D Gareth Evans; C Oliver Hanemann; Theo J M Hulsebos; Kim Hunter-Schaedle; Ganjam V Kalpana; Bruce Korf; Ludwine Messiaen; Laura Papi; Nancy Ratner; Larry S Sherman; Miriam J Smith; Anat O Stemmer-Rachamimov; Jeremie Vitte; Marco Giovannini
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

2.  Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice.

Authors:  C J Guidi; A T Sands; B P Zambrowicz; T K Turner; D A Demers; W Webster; T W Smith; A N Imbalzano; S N Jones
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

3.  Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma.

Authors:  Irene Paganini; Gabriele Lorenzo Capone; Jeremie Vitte; Roberta Sestini; Anna Laura Putignano; Marco Giovannini; Laura Papi
Journal:  J Neurooncol       Date:  2017-12-11       Impact factor: 4.130

4.  Comparative molecular genetic analysis of simian and human HIV-1 integrase interactor INI1/SMARCB1/SNF5.

Authors:  Dohun Pyeon; Lenore Price; In-Woo Park
Journal:  Arch Virol       Date:  2015-09-08       Impact factor: 2.574

5.  Germline mutation of INI1/SMARCB1 in familial schwannomatosis.

Authors:  Theo J M Hulsebos; Astrid S Plomp; Ruud A Wolterman; Els C Robanus-Maandag; Frank Baas; Pieter Wesseling
Journal:  Am J Hum Genet       Date:  2007-02-16       Impact factor: 11.025

6.  Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development.

Authors:  Yasumichi Kuwahara; E Lorena Mora-Blanco; Fatima Banine; Arlin B Rogers; Christopher Fletcher; Larry S Sherman; Charles W M Roberts; Bernard E Weissman
Journal:  Int J Cancer       Date:  2012-12-27       Impact factor: 7.396

7.  LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription.

Authors:  Tyson V Sharp; Fernando Munoz; Dimitra Bourboulia; Nadege Presneau; Eva Darai; Hsei-Wei Wang; Mark Cannon; David N Butcher; Andrew G Nicholson; George Klein; Stephan Imreh; Chris Boshoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-12       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.